Delphy and Bosman van Zaal signed a memorandum of understanding (MOU) in 2021 with Cannabizta B.V. aiming to develop and produce world-class cannabis for the growing demand of medical cannabis in the health industry in Asia, starting with the legalized market in Thailand.
Jeroen van Buren from Delphy (left) shakes hands with Makorn Chaovanich, Cannabizta. (Photo was taken prior COVID-19).
Cannabizta BV combines Dutch technology and knowledge with regional investors to establish a viable and innovative cannabis industry for the supply of the fast-growing markets in Asia (Thailand, Korea, Japan). The signing of the MOU is in line with an international conference on the needs for medical cannabis in Thailand, which was attended by experts from several countries.
The Thai Medical Services Department plays a pivotal role in research into, and development of herbs and cannabis based medicines in Thailand, in an effort to enable patients to get access to alternative medication. The Thai Food and Drug Administration has, so far, approved 218 formulae for cannabis and hemp based cosmetics, such as skin and body care products.